NCT03242967View on ClinicalTrials.gov

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2017

Primary Completion Date

February 12, 2018

Study Completion Date

February 12, 2018

Conditions
AnemiaDialysis-Dependent Chronic Kidney Disease
Interventions
DRUG

Vadadustat

Oral tablet

DRUG

Darbepoetin alfa

subcutaneous or intravenous

Trial Locations (1)

91324

Research Site, Northridge

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY